U.S. market Closed. Opens in 10 hours

ATEC | Alphatec Holdings, Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 8.06 - 8.60
52 Week Range 4.88 - 17.34
Beta 0.85
Implied Volatility 92.14%
IV Rank 48.64%
Day's Volume 3,840,061
Average Volume 2,454,884
Shares Outstanding 141,768,000
Market Cap 1,185,180,480
Sector Healthcare
Industry Medical - Devices
IPO Date 2006-06-12
Valuation
Profitability
Growth
Health
P/E Ratio -6.63
Forward P/E Ratio N/A
EPS -1.26
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 839
Country USA
Website ATEC
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; Sigma transforaminal lumbar interbody fusion pedicle-based access system that provides direct visualization of anatomical landmarks; Sigma PTP Access and Patient Positioning System; squadron lateral retractor designed to maximize patient outcomes; Invictus Spinal Fixation System, a thoracolumbar fixation system to treat a range of pathologies; and Invictus MIS SingleStep System that provides minimally invasive pedicle screw placement. It also provides Invictus Modular Fixation Systems designed to increase adaptability with the power of screw modularity; OsseoScrew system to restore the integrity of the spinal column; Arsenal spinal fixation system, a comprehensive thoracolumbar fixation platform to fix a range of degenerative to deformity pathologies and surgical procedures; Aspida Anterior Lumbar Plating System, a fixation system for anterior lumbar interbody fusion; AMP Anti-Migration Plate; OCT Spinal Fixation System; trestle luxe anterior cervical plate system; and Insignia Anterior Cervical Plate System. In addition, the company offers IdentiTi Porous Ti, Transcend Lateral, and Battalion Posterior Interbody Implants; and biologics consisting of Cervical Structural Allograft Spacers, 3D ProFuse Demineralized Bone Scaffold, Neocore Osteoconductive Matrix, Alphagraft Demineralized and Cellular Bone Matrix, and Amnioshield Amniotic Tissue Barrier, as well as EOS imaging products. It sells its products through a network of independent distributors and direct sales representatives in the United States. The company was founded in 1990 and is headquartered in Carlsbad, California.
ATEC's peers: GMED, OFIX, CNMD, LIVN, KIDS, ITGR, TMCI, ESTA, NUVA, LUNG, SIBN, RXST, SGHT, FNA, AXGN, AORT, SNN
*Chart delayed
Analyzing fundamentals for ATEC we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is very bad and Health is frighteningly weak. For more detailed analysis please see ATEC Fundamentals page.

Watching at ATEC technicals we can see that long-term trend is bearish, while middle-term trend is bullish, as well as bullish short-term trend. More technicals details can be found on ATEC Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙